stella
beta
Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease — Stella
Recruiting
Back to Acral Lentiginous Melanoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
M D Anderson Cancer Center, Houston, Texas
View full record on ClinicalTrials.gov